Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > Hemostemix
View:
Post by BFosheezy on Jan 05, 2021 8:55pm

Hemostemix

Walter(Doc) , I see you over at ceo with the rest of us. I'm a lurker, haven't posted yet on that board. Like you, I have a fairly large amount invested here. I see you at THC as well. I have faith in these phase 2 results being the catalyst we need. Lots of weak hands and profit takers now that shares are free'd up from the split. I dont think many on the FOMO train have done the DD that has been documented over on our other board. As such we are seeing a post split dip, to be expected, from a selling frenzy that will end, leaving the rest of us to ride the wave. Have faith my friend
Comment by Walterthedog on Jan 05, 2021 9:14pm
Amen brutha. All we can do is wait now. I think I've dug into every corner of this thing now and it really will be down to the data at this point. I think management is legit and they seem to be confident that we will pass with flying colors so unless I'm missing something I'd say we have a good shot at a much needed (for me anyways) win.
Comment by BFosheezy on Jan 05, 2021 9:27pm
Things were looking really good back before this whole Kyle Makofka & Aspire problem. A little known fact is Makofka is now the CEO of Aspire, directly after he left and attempted to take the ACP trial data with him causing this lawsuit issue. He was CEO of HEM directly before this lawsuit issue began. The only reason I can come up with is the data was worth attempting a hostile take over ...more  
Comment by BFosheezy on Jan 05, 2021 9:46pm
Also I am LONG on this, its not even about the ACP trials. The NPC pipeline, if at all feasible, is the true diamond here.
Comment by BFosheezy on Jan 05, 2021 9:48pm
NCP-01****
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities